Ignite Creation Date:
2025-12-24 @ 5:59 PM
Ignite Modification Date:
2026-01-25 @ 4:18 AM
Study NCT ID:
NCT02608268
Status:
TERMINATED
Last Update Posted:
2023-12-06
First Post:
2015-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-15
First Submit QC Date:
None
Study First Post Date:
2015-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-08-28
Results First Submit QC Date:
None
Results First Post Date:
2023-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-05
Last Update Post Date:
2023-12-06
Last Update Post Date Type:
ACTUAL